Met Life Investment Management, LLC Abb Vie Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 494,261 shares of ABBV stock, worth $82.9 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
494,261
Previous 506,631 2.44%
Holding current value
$82.9 Million
Previous $86.9 Million 12.32%
% of portfolio
0.57%
Previous 0.52%

Shares

79 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$163.84 - $199.33 $2.03 Million - $2.47 Million
-12,370 Reduced 2.44%
494,261 $97.6 Million
Q2 2024

Aug 13, 2024
BUY
$154.79 - $180.76 $3.14 Million - $3.66 Million
20,261 Added 4.17%
506,631 $86.9 Million
Q1 2024

May 14, 2024
BUY
$159.82 - $182.1 $77.7 Million - $88.6 Million
486,370 New
486,370 $88.6 Million
Q4 2023

Feb 14, 2024
SELL
$137.6 - $154.97 $1.21 Million - $1.36 Million
-8,801 Reduced 1.73%
501,321 $77.7 Million
Q3 2023

May 09, 2024
SELL
$133.59 - $154.65 $2.25 Million - $2.6 Million
-16,836 Reduced 3.19%
510,122 $76 Million
Q3 2023

Apr 29, 2024
SELL
$133.59 - $154.65 $1.5 Million - $1.74 Million
-11,242 Reduced 2.16%
510,122 $76 Million
Q3 2023

Nov 14, 2023
SELL
$133.59 - $154.65 $1.5 Million - $1.74 Million
-11,242 Reduced 2.16%
510,122 $76 Million
Q2 2023

Apr 29, 2024
BUY
$132.51 - $164.9 $69.1 Million - $86 Million
521,364 New
521,364 $70.2 Million
Q2 2023

Aug 10, 2023
SELL
$132.51 - $164.9 $741,260 - $922,450
-5,594 Reduced 1.06%
521,364 $70.2 Million
Q1 2023

May 09, 2024
BUY
$144.61 - $166.54 $76.2 Million - $87.8 Million
526,958 New
526,958 $84 Billion
Q1 2023

May 15, 2023
SELL
$144.61 - $166.54 $766,143 - $882,328
-5,298 Reduced 1.0%
526,958 $84 Million
Q4 2022

May 10, 2024
SELL
$138.31 - $165.87 $1.45 Million - $1.73 Million
-10,453 Reduced 1.93%
532,256 $86.1 Million
Q4 2022

Jun 14, 2023
BUY
$138.31 - $165.87 $732,766 - $878,779
5,298 Added 1.01%
532,256 $86.1 Million
Q4 2022

Mar 22, 2023
SELL
$138.31 - $165.87 $1.45 Million - $1.73 Million
-10,453 Reduced 1.93%
532,256 $86.1 Million
Q4 2022

Feb 15, 2023
SELL
$138.31 - $165.87 $1.45 Million - $1.73 Million
-10,453 Reduced 1.93%
532,256 $86.1 Million
Q3 2022

May 10, 2024
SELL
$134.21 - $153.93 $778,015 - $892,332
-5,797 Reduced 1.06%
542,709 $72.8 Million
Q3 2022

Jun 14, 2023
BUY
$134.21 - $153.93 $2.11 Million - $2.42 Million
15,751 Added 2.99%
542,709 $72.8 Million
Q3 2022

Mar 22, 2023
SELL
$134.21 - $153.93 $778,015 - $892,332
-5,797 Reduced 1.06%
542,709 $72.8 Million
Q3 2022

Nov 14, 2022
SELL
$134.21 - $153.93 $778,015 - $892,332
-5,797 Reduced 1.06%
542,709 $72.8 Million
Q2 2022

May 10, 2024
SELL
$137.62 - $174.96 $1.6 Million - $2.03 Million
-11,627 Reduced 2.08%
548,506 $84 Million
Q2 2022

Jun 20, 2023
BUY
$137.62 - $174.96 $2.97 Million - $3.77 Million
21,548 Added 4.09%
548,506 $84 Million
Q2 2022

Mar 22, 2023
SELL
$137.62 - $174.96 $1.6 Million - $2.03 Million
-11,627 Reduced 2.08%
548,506 $84 Million
Q2 2022

Aug 11, 2022
SELL
$137.62 - $174.96 $1.6 Million - $2.03 Million
-11,627 Reduced 2.08%
548,506 $84 Million
Q1 2022

May 10, 2024
BUY
$131.98 - $163.75 $73.9 Million - $91.7 Million
560,133 New
560,133 $90.8 Million
Q1 2022

Jun 20, 2023
BUY
$131.98 - $163.75 $4.38 Million - $5.43 Million
33,175 Added 6.3%
560,133 $90.8 Million
Q1 2022

Mar 22, 2023
BUY
$131.98 - $163.75 $22.4 Million - $27.8 Million
169,534 Added 43.4%
560,133 $90.8 Million
Q1 2022

May 12, 2022
BUY
$131.98 - $163.75 $22.4 Million - $27.8 Million
169,534 Added 43.4%
560,133 $90.8 Million
Q4 2021

May 17, 2024
SELL
$107.43 - $135.93 $917,022 - $1.16 Million
-8,536 Reduced 2.14%
390,599 $52.9 Million
Q4 2021

Jun 21, 2023
SELL
$107.43 - $135.93 $14.6 Million - $18.5 Million
-136,359 Reduced 25.88%
390,599 $52.9 Million
Q4 2021

Mar 22, 2023
SELL
$107.43 - $135.93 $917,022 - $1.16 Million
-8,536 Reduced 2.14%
390,599 $52.9 Million
Q4 2021

Feb 15, 2022
SELL
$107.43 - $135.93 $917,022 - $1.16 Million
-8,536 Reduced 2.14%
390,599 $52.9 Million
Q3 2021

May 17, 2024
SELL
$106.4 - $120.78 $1.1 Million - $1.25 Million
-10,355 Reduced 2.53%
399,135 $43.1 Million
Q3 2021

Jun 21, 2023
SELL
$106.4 - $120.78 $13.6 Million - $15.4 Million
-127,823 Reduced 24.26%
399,135 $43.1 Million
Q3 2021

Mar 22, 2023
SELL
$106.4 - $120.78 $1.1 Million - $1.25 Million
-10,355 Reduced 2.53%
399,135 $43.1 Million
Q3 2021

Nov 15, 2021
SELL
$106.4 - $120.78 $1.1 Million - $1.25 Million
-10,355 Reduced 2.53%
399,135 $43.1 Million
Q2 2021

May 17, 2024
SELL
$105.21 - $117.21 $1.19 Million - $1.33 Million
-11,319 Reduced 2.69%
409,490 $46.1 Million
Q2 2021

Jun 21, 2023
SELL
$105.21 - $117.21 $12.4 Million - $13.8 Million
-117,468 Reduced 22.29%
409,490 $46.1 Million
Q2 2021

Mar 22, 2023
SELL
$105.21 - $117.21 $1.42 Million - $1.58 Million
-13,464 Reduced 3.18%
409,490 $46.1 Million
Q2 2021

Aug 16, 2021
SELL
$105.21 - $117.21 $1.42 Million - $1.58 Million
-13,464 Reduced 3.18%
409,490 $46.1 Million
Q1 2021

May 17, 2024
SELL
$102.3 - $112.62 $6.71 Million - $7.38 Million
-65,561 Reduced 13.48%
420,809 $45.5 Million
Q1 2021

Jun 26, 2023
SELL
$102.3 - $112.62 $10.9 Million - $12 Million
-106,149 Reduced 20.14%
420,809 $45.5 Billion
Q1 2021

Mar 22, 2023
SELL
$102.3 - $112.62 $593,340 - $653,196
-5,800 Reduced 1.35%
422,954 $45.8 Million
Q1 2021

May 14, 2021
SELL
$102.3 - $112.62 $593,340 - $653,196
-5,800 Reduced 1.35%
422,954 $45.8 Million
Q4 2020

May 24, 2024
SELL
$80.49 - $108.67 $1.51 Million - $2.03 Million
-18,708 Reduced 4.18%
428,754 $45.9 Million
Q4 2020

Jun 22, 2023
SELL
$80.49 - $108.67 $7.9 Million - $10.7 Million
-98,204 Reduced 18.64%
428,754 $45.9 Million
Q4 2020

Mar 22, 2023
SELL
$80.49 - $108.67 $1.51 Million - $2.03 Million
-18,708 Reduced 4.18%
428,754 $45.9 Million
Q4 2020

Feb 16, 2021
SELL
$80.49 - $108.67 $1.51 Million - $2.03 Million
-18,708 Reduced 4.18%
428,754 $45.9 Million
Q3 2020

May 24, 2024
SELL
$85.91 - $100.83 $1.16 Million - $1.36 Million
-13,456 Reduced 2.92%
447,462 $39.2 Billion
Q3 2020

Jun 26, 2023
SELL
$85.91 - $100.83 $6.83 Million - $8.02 Million
-79,496 Reduced 15.09%
447,462 $39.2 Million
Q3 2020

Mar 22, 2023
SELL
$85.91 - $100.83 $1.16 Million - $1.36 Million
-13,456 Reduced 2.92%
447,462 $39.2 Million
Q3 2020

Nov 13, 2020
SELL
$85.91 - $100.83 $1.16 Million - $1.36 Million
-13,456 Reduced 2.92%
447,462 $39.2 Million
Q2 2020

May 24, 2024
SELL
$73.37 - $98.18 $1.87 Million - $2.5 Million
-25,452 Reduced 5.23%
460,918 $45.3 Billion
Q2 2020

Jun 26, 2023
SELL
$73.37 - $98.18 $4.85 Million - $6.48 Million
-66,040 Reduced 12.53%
460,918 $45.3 Million
Q2 2020

Mar 22, 2023
BUY
$73.37 - $98.18 $5.85 Million - $7.83 Million
79,733 Added 20.92%
460,918 $45.3 Million
Q2 2020

Aug 14, 2020
BUY
$73.37 - $98.18 $5.85 Million - $7.83 Million
79,733 Added 20.92%
460,918 $45.3 Million
Q1 2020

Jul 12, 2023
SELL
$64.5 - $97.79 $9.4 Million - $14.3 Million
-145,773 Reduced 27.66%
381,185 $29 Million
Q1 2020

Mar 22, 2023
SELL
$64.5 - $97.79 $752,263 - $1.14 Million
-11,663 Reduced 2.97%
381,185 $29 Million
Q1 2020

May 15, 2020
SELL
$64.5 - $97.79 $752,263 - $1.14 Million
-11,663 Reduced 2.97%
381,185 $29 Million
Q4 2019

Jul 12, 2023
SELL
$72.13 - $90.25 $9.67 Million - $12.1 Million
-134,110 Reduced 25.45%
392,848 $34.8 Million
Q4 2019

Mar 22, 2023
SELL
$72.13 - $90.25 $685,307 - $857,465
-9,501 Reduced 2.36%
392,848 $34.8 Million
Q4 2019

Feb 14, 2020
SELL
$72.13 - $90.25 $685,307 - $857,465
-9,501 Reduced 2.36%
392,848 $34.8 Million
Q3 2019

Jul 12, 2023
SELL
$62.98 - $75.72 $7.85 Million - $9.44 Million
-124,609 Reduced 23.65%
402,349 $30.5 Million
Q3 2019

Mar 22, 2023
SELL
$62.98 - $75.72 $323,528 - $388,973
-5,137 Reduced 1.26%
402,349 $30.5 Million
Q3 2019

Nov 14, 2019
SELL
$62.98 - $75.72 $323,528 - $388,973
-5,137 Reduced 1.26%
402,349 $30.5 Million
Q2 2019

Jul 12, 2023
SELL
$65.7 - $83.98 $7.85 Million - $10 Million
-119,472 Reduced 22.67%
407,486 $29.6 Million
Q2 2019

Mar 22, 2023
SELL
$65.7 - $83.98 $780,516 - $997,682
-11,880 Reduced 2.83%
407,486 $29.6 Million
Q2 2019

Aug 14, 2019
SELL
$65.7 - $83.98 $780,516 - $997,682
-11,880 Reduced 2.83%
407,486 $29.6 Million
Q1 2019

Jul 13, 2023
SELL
$77.14 - $90.79 $8.3 Million - $9.77 Million
-107,592 Reduced 20.42%
419,366 $33.8 Million
Q1 2019

Mar 22, 2023
SELL
$77.14 - $90.79 $835,271 - $983,074
-10,828 Reduced 2.52%
419,366 $33.8 Million
Q1 2019

May 15, 2019
SELL
$77.14 - $90.79 $835,271 - $983,074
-10,828 Reduced 2.52%
419,366 $33.8 Million
Q4 2018

Jul 13, 2023
SELL
$77.85 - $96.01 $7.53 Million - $9.29 Million
-96,764 Reduced 18.36%
430,194 $39.7 Million
Q4 2018

Mar 22, 2023
SELL
$77.85 - $96.01 $803,334 - $990,727
-10,319 Reduced 2.34%
430,194 $39.7 Million
Q4 2018

Feb 14, 2019
SELL
$77.85 - $96.01 $803,334 - $990,727
-10,319 Reduced 2.34%
430,194 $39.7 Million
Q3 2018

Jul 13, 2023
SELL
$88.91 - $98.84 $7.69 Million - $8.54 Million
-86,445 Reduced 16.4%
440,513 $41.7 Million
Q3 2018

Mar 22, 2023
SELL
$88.91 - $98.84 $8.16 Million - $9.07 Million
-91,743 Reduced 17.24%
440,513 $41.7 Million
Q3 2018

Nov 14, 2018
SELL
$88.91 - $98.84 $498,696 - $554,393
-5,609 Reduced 1.26%
440,513 $41.7 Million
Q2 2018

Aug 15, 2018
SELL
$89.78 - $106.23 $3.02 Million - $3.57 Million
-33,604 Reduced 7.0%
446,122 $41.3 Million
Q1 2018

May 15, 2018
SELL
$92.01 - $123.21 $1.24 Million - $1.66 Million
-13,500 Reduced 2.74%
479,726 $45.4 Million
Q4 2017

Feb 15, 2018
BUY
$89.56 - $98.21 $44.2 Million - $48.4 Million
493,226
493,226 $47.7 Million

Others Institutions Holding ABBV

# of Institutions
3,846
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email